Poly‐l‐lactic acid for HIV‐1 facial lipoatrophy: 48‐week follow‐up

Objectives Poly‐l‐lactic acid (PLA) injections modestly increase objectively assessed facial thickness but not facial soft tissue volume (FSTV) over 24 weeks. The durability of this response has not been well defined objectively. Methods HIV‐infected lipoatrophic adults were randomized to four open‐...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2009-03, Vol.10 (3), p.163-172
Hauptverfasser:	Carey, D, Baker, D, Petoumenos, K, Chuah, J, Rogers, GD, Watson, J, Cooper, DA, Emery, S, Carr, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Cosmetic Techniques Face Female Follow-Up Studies HIV HIV-1 HIV-Associated Lipodystrophy Syndrome - drug therapy HIV-Associated Lipodystrophy Syndrome - psychology Human immunodeficiency virus 1 Humans Injections, Subcutaneous Lactic Acid - administration & dosage lipoatrophy Male Polyesters Polymers - administration & dosage poly‐l‐lactic acid Quality of Life - psychology Severity of Illness Index Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!